2,069 Shares in The Allstate Corporation $ALL Acquired by Triumph Capital Management

Key Points

• Triumph Capital Management acquired 2,069 shares of The Allstate Corporation, valued at approximately $417,000, in the second quarter.
• Allstate's recent earnings report showed a significant increase in earnings per share (EPS) at $5.94, surpassing analysts' expectations of $3.20.
• The company declared a $1.00 quarterly dividend, with a yield of 2.0%, to be paid on October 1st, following a record date of August 29th.

Triumph Capital Management purchased a new position in shares of The Allstate Corporation (NYSE:ALL - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,069 shares of the insurance provider's stock, valued at approximately $417,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of ALL. Price T Rowe Associates Inc. MD increased its position in Allstate by 25.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider's stock worth $2,424,710,000 after purchasing an additional 2,374,684 shares during the last quarter. Boston Partners increased its position in Allstate by 613.9% during the first quarter. Boston Partners now owns 2,482,654 shares of the insurance provider's stock worth $512,627,000 after purchasing an additional 2,134,893 shares during the last quarter. GAMMA Investing LLC increased its position in Allstate by 25,026.1% during the first quarter. GAMMA Investing LLC now owns 1,273,895 shares of the insurance provider's stock worth $263,785,000 after purchasing an additional 1,268,825 shares during the last quarter. Mackenzie Financial Corp increased its position in Allstate by 261.6% during the fourth quarter. Mackenzie Financial Corp now owns 832,902 shares of the insurance provider's stock worth $160,575,000 after purchasing an additional 602,533 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its position in Allstate by 27.2% during the first quarter. Goldman Sachs Group Inc. now owns 2,328,070 shares of the insurance provider's stock worth $482,073,000 after purchasing an additional 497,982 shares during the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.

Allstate Trading Down 0.3%

NYSE ALL opened at $196.27 on Wednesday. The Allstate Corporation has a 12 month low of $176.00 and a 12 month high of $214.76. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43. The company has a market capitalization of $51.72 billion, a price-to-earnings ratio of 9.23, a price-to-earnings-growth ratio of 0.79 and a beta of 0.37. The company's fifty day moving average price is $201.10 and its two-hundred day moving average price is $200.45.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.20 by $2.74. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The company had revenue of $15.05 billion for the quarter, compared to the consensus estimate of $16.59 billion. During the same period last year, the firm posted $1.61 EPS. The company's revenue for the quarter was up 5.8% on a year-over-year basis. As a group, research analysts predict that The Allstate Corporation will post 18.74 earnings per share for the current fiscal year.

Allstate Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, August 29th will be given a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Friday, August 29th. Allstate's dividend payout ratio (DPR) is presently 18.81%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Wall Street Zen raised shares of Allstate from a "hold" rating to a "buy" rating in a research report on Tuesday, August 5th. Citigroup raised shares of Allstate to a "hold" rating in a research report on Wednesday, August 13th. UBS Group increased their price objective on shares of Allstate from $230.00 to $235.00 and gave the stock a "buy" rating in a research report on Wednesday, July 9th. Cantor Fitzgerald raised shares of Allstate to a "hold" rating in a research report on Wednesday, August 13th. Finally, BMO Capital Markets increased their price objective on shares of Allstate from $230.00 to $235.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 20th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $231.47.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.